Is long-acting HIV treatment as effective as daily pills? Early results say yes—with some risks of resistance in rare cases.

Quebec is the first province to publicly cover costs of long-acting injectable HIV prevention medication Apretude. Experts say it's a much-needed, long-awaited tool — and they're pushing to make it ...

PEPFAR had been set to lead the rollout of Gilead Science's lenacapavir, which has been hailed as a "miracle" of HIV ...

Human immunodeficiency virus, if untreated, causes acquired immunodeficiency syndrome (AIDS), and death. HIV is almost entirely preventable by using condoms, or by taking PrEP drugs. PrEP drugs do not ...

When illness progression or treatment failure occurs on ART, it is often a result of drug-resistant HIV. The mass layoffs initiated by HHS this week, including in the upper echelons of the NIH ...

mimicking a scenario in which information on drug resistance testing is unavailable at treatment initiation. The primary endpoint was the percentage of participants with < 50 copies/mL of HIV-1 ...